During the last session, Timber Pharmaceuticals, Inc. (NYSE:TMBR)’s traded shares were 3,200,000,000, with the beta value of the company hitting 0.39. At the end of the trading day, the stock’s price was $2, reflecting an intraday loss of -11.11% or -$0.25. The 52-week high for the TMBR share is $10.44, that puts it down -422% from that peak though still a striking +66.75% gain since the share price plummeted to a 52-week low of $0.665. The company’s market capitalization is $73.69 Million, and the average intraday trading volume over the past 10 days was 3.35 Million shares, and the average trade volume was 10.85 Million shares over the past three months.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Timber Pharmaceuticals, Inc. (TMBR) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 3. TMBR has a Sell rating from none of the analyst(s) out of 1 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while none of them suggest Overweight, and no one recommend a Buy rating for it. None of the analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.

Timber Pharmaceuticals, Inc. (NYSE:TMBR): Trading Information

Timber Pharmaceuticals, Inc. (TMBR) registered a -11.11% downside in the last session and has traded in the red over the past 5 sessions. The stock spiked 16.32% in intraday trading to $2.39- this Thursday, Apr 01, hitting a weekly high. The stock’s 5-day price performance is -3.85%, and it has moved by 2.04% in 30 days. Based on these gigs, the overall price performance for the year is 169.18%. The short interest in Timber Pharmaceuticals, Inc. (NYSE:TMBR) is 3.78 Million shares and it means that shorts have 0.35 day(s) to cover.

The consensus price target of analysts on Wall Street is $12, which implies an increase of 500% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $12 and $12 respectively. As a result, TMBR is trading at a discount of 500% off the target high and 500% off the low.

Timber Pharmaceuticals, Inc. (TMBR) projections and forecasts

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 67.5%. While earnings are projected to return 89.2% in 2021, the next five years will return 0% per annum.

Timber Pharmaceuticals, Inc. (NYSE:TMBR)’s Biggest Investors

Timber Pharmaceuticals, Inc. insiders own 15.26% of total outstanding shares while institutional holders control 3.38%, with the float percentage being 3.99%. Bridgeway Capital Management, Inc. is the largest shareholder of the company, while 12 institutions own stock in it. As of Dec 30, 2020, the company held over 158.3 Thousand shares (or 0.43% of all shares), a total value of $117.62 Thousand in shares.

The next largest institutional holding, with 17.58 Thousand shares, is of Two Sigma Securities, LLC’s that is approximately 0.05% of outstanding shares. At the market price on Dec 30, 2020, these shares were valued at $13.06 Thousand.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Also, the Mutual Funds coming in first place with the largest holdings of Timber Pharmaceuticals, Inc. (TMBR) shares are Bridgeway Funds Inc-Ultra Small Company Fund and Bridgeway Funds Inc-Ultra Small Company Market Fund. Data provided on Dec 30, 2020 indicates that Bridgeway Funds Inc-Ultra Small Company Fund owns about 107,800 shares. This amounts to just over 0.29 percent of the company’s overall shares, with a $80.1 Thousand market value. The same data shows that the other fund manager holds slightly less at 44.1 Thousand, or about 0.12% of the stock, which is worth about $32.77 Thousand.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

LEAVE A REPLY

Please enter your comment!
Please enter your name here